Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients

References

Page 1

	Year	Citations
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin, New England Journal of Medicine	2020	15.1K
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine New England Journal of Medicine	2020	10.4K
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael, New England Journal of Medicine	2020	3.4K
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting Noa Dagan, Noam Barda, Eldad Kepten, New England Journal of Medicine	2021	2.8K
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates Edward E. Walsh, Robert W. Frenck, Ann R. Falsey, New England Journal of Medicine	2020	2.7K
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses Uğur Şahin, Alexander Muik, Evelyna Derhovanessian, Nature VaccinologyVaccinationVaccine DevelopmentHuman AntibodyImmunology	2020	2K
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults Evan J. Anderson, Nadine Rouphael, Alicia T. Widge, New England Journal of Medicine	2020	1.6K
Presentation and Outcomes of Patients with ESKD and COVID-19 Anthony M. Valeri, Shelief Y. Robbins-Juarez, Jacob S. Stevens, Journal of the American Society of Nephrology	2020	367
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus Ayelet Grupper, Liane Rabinowich, Doron Schwartz, American Journal of Transplantation	2021	358
Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis Ayelet Grupper, Nechama Sharon, Talya Finn, Clinical Journal of the American Society of Nephrology	2021	343

Page 1